Pharma Logistics Market has Evolved Significantly After the Outbreak of the COVID-19 Pandemic, with Vaccine Distributions Getting Streamlined. The Market is Set to Reach USD 146.71 Billion By 2027 - Arizton

According to Arizton's latest research report, the pharmaceutical logistics market is expected to grow at a CAGR of 8% during 2021-2027. Increased usage of logistics optimization tools, AI, IoT, and intelligent logistics platforms are likely to contribute to the future growth of the pharmaceutical logistics market. North America region accounts for the highest revenue share of 38.70% in the global pharmaceutical logistics market in 2021 and holds the presence of most pharmaceutical suppliers. The US is the leading country worldwide with the highest share of pharmaceuticals. About five top pharmaceutical companies in 2020 were from the US. In the US, branded drugs accounted for around 83.9% of spending. In 2020, about 8.1% of worldwide drug and medicine shipments originated from North America.
Cold chain logistics companies have made a huge footprint since the onset of COVID-19 pandemic due to the growing demand for temperature-controlled biologics, especially vaccines. Since the beginning of 2020, the adoption of state-of-the-art technologies such as telematics and remote monitoring in cold chain logistics is making transportation in the pharmaceutical industry more efficient with better safety and connectivity.
On an average, a drug manufacturer can expect a damage rate of around 30% owing to the logistics constraints associated with a pharmaceutical product. In fact, around 25% of vaccines that reach their destination deteriorate due to incorrect shipping, while around 20% of temperature-sensitive drugs experience broken cold chains. As a result, pharma & biotech companies are utilizing logistics from expert logistic providers who can seamlessly deliver drugs across the supply chain, thereby contributing to the overall growth of the market.
Third-party logistics companies are utilizing cloud computing solutions and installing IoT devices in refrigerated trucks and containers to facilitate real-time remote temperature monitoring during the transportation of temperature-sensitive drugs and vaccines.

Click Here to Download the Free Sample Report:https://www.arizton.com/request-sample/3606

Digital transformation is expected to offer an opportunity for pharmaceutical logistics companies to gain a competitive advantage. Digitalization can be extremely beneficial to both small and large firms in the pharmaceutical industry. For example, digitalization to develop counterfeit-proof pharmaceuticals with trackable serial numbers to ensure quality while satisfying forthcoming serialization regulations. Pharmaceutical firms can also embrace digitization to fulfill the predicted rise in demand from global markets. They may use digitalization to comply with regulations, uncover manufacturing efficiencies to reduce costs, and swiftly interact with suppliers and distributors using cloud-based information exchanges.
DB Schenker, a subsidiary of DB Group, a leading provider in the logistics sector, uses technologies and methods of digitalization to offer customers an attractive range of products. On the one hand, it is incorporating new transport offers into its product portfolio, such as on-demand mobility, and establishing new platforms for its customer interfaces. On the other hand, it supports internal processes with technologies, such as AI, so the company can continue to offer customers fair prices with efficient processes. According to the company, the shift to digital rail operations and digitalization of infrastructure and vehicles is essential to increase transport density and reliability.
In 2019, TrakCel, one of the global leaders in managing clinical supply chain logistics, partnered with Quick Group (provides priority logistics and transportation solutions for time and temperature-sensitive life science and healthcare products) to provide industry-leading digital supply chain IT solutions for cell and gene therapies. TrakCel is the first provider of integrated cellular orchestration solutions for tracking cell and gene therapy products. Its goal is to provide cell and gene therapy software solutions.

Customization Request If our report does not include the information you are searching for, you may contact us to have a report tailored to your specific business needs https://www.arizton.com/customize-report/3606

WHY SHOULD YOU BUY THIS RESEARCH REPORT?
• In-depth data and analysis of the global pharmaceutical logistics market's growth over the ensuing six years.
• Global pharmaceutical logistics extensions market size estimation and contribution in the market.
• Predictions on upcoming trends and changes in consumer behavior.
• Analysis of the market's competitive environment and exhaustive vendor information.
• Detailed information on the variables posing challenges to vendors in the global pharmaceutical logistics market.

The report considers the present scenario of the pharmaceutical logistics market and its market dynamics for 2022-2027. It covers a detailed overview of several market growth enablers, restraints, and trends. The study covers both the demand and supply sides of the market. It also profiles and analyzes leading companies and several other prominent companies operating in the market.

Know more about the market: https://www.arizton.com/market-reports/pharmaceutical-logistics-market

KEY LEADING VENDORS
• AmerisourceBergen
• CEVA Logistics
• DB Group
• Deutsche Post DHL
• FedEx
• Kuehne + Nagel
• United Parcel Service
• ABS Logistics
• AWL India
• Alloga
• BOLLORÉ LOGISTICS
• Cardinal Health
• C.H. Robinson
• Cold Chain Technologies
• CRYOPDP
• DPD
• DSV
• Farmasoft
• Jeena & Company
• Lufthansa Cargo
• Maersk
• Medline
• Nippon Express
• Noatum Logistics
• Owens & Minor
• Oximio
• Pharma Logistics
• PHOENIX Group
• Parexel International
• SEKO Logistics
• Singapore Post
• SINOTRANS
• XPO Logistics
• Yourway
• YUSEN LOGISTICS

MARKET SEGMENTATION
Therapy Area
• Communicable Diseases
• Oncology
• Diabetes
• Cardiovascular Diseases
• Autoimmune Diseases
• Neurological Disorders
• Pain Management
• Respiratory Diseases
• Others
Origin
• Branded
• Generic
• OTC
Product
• Small Molecule Drugs
• Biologics
Function
• Transportation
• Warehousing
• Others
Geography
• North America
o US
o Canada
• Europe
o Germany
o Italy
o Spain
o France
o UK
• APAC
o Japan
o China
o South Korea
o India
o Australia
• Latin America
o Brazil
o Mexico
o Argentina
• Middle East & Africa
o Turkey
o Saudi Arabia
o South Africa

TABLE OF CONTENT
1 RESEARCH METHODOLOGY
2 RESEARCH OBJECTIVES
3 RESEARCH PROCESS
4 SCOPE & COVERAGE
4.1 MARKET DEFINITION
4.1.1 INCLUSIONS
4.1.2 EXCLUSIONS
4.1.3 MARKET ESTIMATION CAVEATS
4.2 BASE YEAR
4.3 SCOPE OF THE STUDY
4.3.1 MARKET SEGMENTATION BY THERAPY AREA
4.3.2 MARKET SEGMENTATION BY ORIGIN
4.3.3 MARKET SEGMENTATION BY PRODUCT
4.3.4 MARKET SEGMENTATION BY FUNCTION
4.3.5 MARKET SEGMENTATION BY GEOGRAPHY
5 REPORT ASSUMPTIONS & CAVEATS
5.1 KEY CAVEATS
5.2 CURRENCY CONVERSION
5.3 MARKET DERIVATION
6 MARKET AT A GLANCE
7 INTRODUCTION
7.1 BACKGROUND
7.2 IMPACT OF COVID-19 ON THE GLOBAL SUPPLY CHAIN
8 PREMIUM INSIGHTS
9 MARKET OPPORTUNITIES & TRENDS
9.1 GROWING DEMAND FOR CLINICAL TRIALS LOGISTICS
9.2 DIGITAL TRANSFORMATIONS IN PHARMA LOGISTICS
9.3 INCREASING DEMAND FOR CELL & GENE THERAPY LOGISTICS
10 MARKET GROWTH ENABLERS
10.1 INCREASING DEMAND FOR TEMPERATURE-SENSITIVE MEDICINES
10.2 GROWING DEMAND FOR OCEAN FREIGHT SERVICE
10.3 INCREASING DEMAND FOR GENERICS AND BIOSIMILARS
11 MARKET RESTRAINTS
11.1 LACK OF COMPLIANCE AND CHANGING REGULATIONS
11.2 IMPACT OF THE COVID-19 PANDEMIC
11.3 GEOPOLITICAL RISKS & CHANGES IN INTERNATIONAL TRADE POLICIES AND RELATIONS
12 MARKET LANDSCAPE
12.1 MARKET OVERVIEW
12.2 MARKET SIZE & FORECAST
12.2.1 INSIGHTS BY THERAPY AREA
12.2.2 INSIGHTS BY ORIGIN
12.2.3 INSIGHTS BY PRODUCT
12.2.4 INSIGHTS BY FUNCTION
12.2.5 INSIGHTS BY GEOGRAPHY
12.3 FIVE FORCES ANALYSIS
12.3.1 THREAT OF NEW ENTRANTS
12.3.2 BARGAINING POWER OF SUPPLIERS
12.3.3 BARGAINING POWER OF BUYERS
12.3.4 THREAT OF SUBSTITUTES
12.3.5 COMPETITIVE RIVALRY
13 THERAPY AREA
13.1 MARKET SNAPSHOT & GROWTH ENGINE
13.2 MARKET OVERVIEW
13.3 COMMUNICABLE DISEASES
13.3.1 MARKET OVERVIEW
13.3.2 MARKET SIZE & FORECAST
13.3.3 MARKET BY GEOGRAPHY
13.4 ONCOLOGY
13.4.1 MARKET OVERVIEW
13.4.2 MARKET SIZE & FORECAST
13.4.3 MARKET BY GEOGRAPHY
13.5 DIABETES
13.5.1 MARKET OVERVIEW
13.5.2 MARKET SIZE & FORECAST
13.5.3 MARKET BY GEOGRAPHY
13.6 CARDIOVASCULAR DISEASES
13.6.1 MARKET OVERVIEW
13.6.2 MARKET SIZE & FORECAST
13.6.3 MARKET BY GEOGRAPHY
13.7 AUTOIMMUNE DISEASES
13.7.1 MARKET OVERVIEW
13.7.2 MARKET SIZE & FORECAST
13.7.3 MARKET BY GEOGRAPHY
13.8 NEUROLOGICAL DISORDERS
13.8.1 MARKET OVERVIEW
13.8.2 MARKET SIZE & FORECAST
13.8.3 MARKET BY GEOGRAPHY
13.9 PAIN MANAGEMENT
13.9.1 MARKET OVERVIEW
13.9.2 MARKET SIZE & FORECAST
13.9.3 MARKET BY GEOGRAPHY
13.10 RESPIRATORY DISEASES
13.10.1 MARKET OVERVIEW
13.10.2 MARKET SIZE & FORECAST
13.10.3 MARKET BY GEOGRAPHY
13.11 OTHERS
13.11.1 MARKET OVERVIEW
13.11.2 MARKET SIZE & FORECAST
13.11.3 MARKET BY GEOGRAPHY
14 ORIGIN
14.1 MARKET SNAPSHOT & GROWTH ENGINE
14.2 MARKET OVERVIEW
14.3 BRANDED DRUGS
14.3.1 MARKET OVERVIEW
14.3.2 MARKET SIZE & FORECAST
14.3.3 MARKET BY GEOGRAPHY
14.4 GENERIC DRUGS
14.4.1 MARKET OVERVIEW
14.4.2 MARKET SIZE & FORECAST
14.4.3 MARKET BY GEOGRAPHY
14.5 OTC
14.5.1 MARKET OVERVIEW
14.5.2 MARKET SIZE & FORECAST
14.5.3 MARKET BY GEOGRAPHY
15 PRODUCT
15.1 MARKET SNAPSHOT & GROWTH ENGINE
15.2 MARKET OVERVIEW
15.3 SMALL MOLECULE DRUGS
15.3.1 MARKET OVERVIEW
15.3.2 MARKET SIZE & FORECAST
15.3.3 MARKET BY GEOGRAPHY
15.4 BIOLOGICS
15.4.1 MARKET OVERVIEW
15.4.2 MARKET SIZE & FORECAST
15.4.3 MARKET BY GEOGRAPHY
15.5 MONOCLONAL ANTIBODIES
15.5.1 MARKET OVERVIEW
15.5.2 MARKET SIZE & FORECAST
15.6 VACCINES
15.6.1 MARKET OVERVIEW
15.6.2 MARKET SIZE & FORECAST
15.7 OTHERS
15.7.1 MARKET OVERVIEW
15.7.2 MARKET SIZE & FORECAST
16 FUNCTION
16.1 MARKET SNAPSHOT & GROWTH ENGINE
16.2 MARKET OVERVIEW
16.3 TRANSPORTATION
16.3.1 MARKET OVERVIEW
16.3.2 MARKET SIZE & FORECAST
16.3.3 MARKET BY GEOGRAPHY
16.4 ROAD
16.4.1 MARKET OVERVIEW
16.4.2 MARKET SIZE & FORECAST
16.5 WATER
16.5.1 MARKET OVERVIEW
16.5.2 MARKET SIZE & FORECAST
16.6 AIR
16.6.1 MARKET OVERVIEW
16.6.2 MARKET SIZE & FORECAST
16.7 WAREHOUSING
16.7.1 MARKET OVERVIEW
16.7.2 MARKET SIZE & FORECAST
16.7.3 MARKET BY GEOGRAPHY
16.8 OTHERS
16.8.1 MARKET OVERVIEW
16.8.2 MARKET SIZE & FORECAST
16.8.3 MARKET BY GEOGRAPHY
17 GEOGRAPHY
17.1 MARKET SNAPSHOT & GROWTH ENGINE
17.2 GEOGRAPHIC OVERVIEW
18 NORTH AMERICA
18.1 MARKET OVERVIEW
18.2 MARKET SIZE & FORECAST
18.3 NORTH AMERICA BY THERAPY AREA
18.4 NORTH AMERICA BY ORIGIN
18.5 NORTH AMERICA BY PRODUCT
18.6 NORTH AMERICA BY FUNCTION
18.7 KEY COUNTRIES
18.7.1 US: MARKET SIZE & FORECAST
18.7.2 CANADA: MARKET SIZE & FORECAST
19 EUROPE
19.1 MARKET OVERVIEW
19.2 MARKET SIZE & FORECAST
19.3 EUROPE BY THERAPY AREA
19.4 EUROPE BY ORIGIN
19.5 EUROPE BY PRODUCT
19.6 EUROPE BY FUNCTION
19.7 KEY COUNTRIES
19.7.1 GERMANY: MARKET SIZE & FORECAST
19.7.2 FRANCE: MARKET SIZE & FORECAST
19.7.3 UK: MARKET SIZE & FORECAST
19.7.4 ITALY: MARKET SIZE & FORECAST
19.7.5 SPAIN: MARKET SIZE & FORECAST
20 APAC
20.1 MARKET OVERVIEW
20.2 MARKET SIZE & FORECAST
20.3 APAC BY THERAPY AREA
20.4 APAC BY ORIGIN
20.5 APAC BY PRODUCT
20.6 APAC BY FUNCTION
20.7 KEY COUNTRIES
20.7.1 CHINA: MARKET SIZE & FORECAST
20.7.2 JAPAN: MARKET SIZE & FORECAST
20.7.3 INDIA: MARKET SIZE & FORECAST
20.7.4 SOUTH KOREA: MARKET SIZE & FORECAST
20.7.5 AUSTRALIA: MARKET SIZE & FORECAST
21 LATIN AMERICA
21.1 MARKET OVERVIEW
21.2 MARKET SIZE & FORECAST
21.3 LATIN AMERICA BY THERAPY AREA
21.4 LATIN AMERICA BY ORIGIN
21.5 LATIN AMERICA BY PRODUCT
21.6 LATIN AMERICA BY FUNCTION
21.7 KEY COUNTRIES
21.7.1 BRAZIL: MARKET SIZE & FORECAST
21.7.2 MEXICO: MARKET SIZE & FORECAST
21.7.3 ARGENTINA: MARKET SIZE & FORECAST
22 MIDDLE EAST & AFRICA
22.1 MARKET OVERVIEW
22.2 MARKET SIZE & FORECAST
22.3 MIDDLE EAST & AFRICA BY THERAPY AREA
22.4 MIDDLE EAST & AFRICA BY ORIGIN
22.5 MIDDLE EAST & AFRICA BY PRODUCT
22.6 MIDDLE EAST & AFRICA BY FUNCTION
22.7 KEY COUNTRIES
22.7.1 TURKEY: MARKET SIZE & FORECAST
22.7.2 SAUDI ARABIA: MARKET SIZE & FORECAST
22.7.3 SOUTH AFRICA: MARKET SIZE & FORECAST
23 COMPETITIVE LANDSCAPE
23.1 COMPETITION OVERVIEW
23.1.1 AMERISOURCEBERGEN
23.1.2 DB GROUP
23.1.3 DEUTSCHE POST DHL
23.1.4 CEVA LOGISTICS
23.1.5 UNITED PARCEL SERVICE
23.1.6 FEDEX
23.1.7 KUEHNE+NAGEL

24 KEY COMPANY PROFILES
24.1 AMERISOURCEBERGEN
24.1.1 BUSINESS OVERVIEW
24.1.2 SERVICE OFFERINGS
24.1.3 KEY STRATEGIES
24.1.4 KEY STRENGTHS
24.1.5 KEY OPPORTUNITIES
24.2 CEVA LOGISTICS
24.3 DB GROUP
24.4 DEUTSCHE POST DHL
24.5 FEDEX
24.6 KUEHNE + NAGEL
24.7 UNITED PARCEL SERVICE
25 OTHER PROMINENT VENDORS
25.1 ABS LOGISTICS
25.1.1 BUSINESS OVERVIEW
25.1.2 SERVICE OFFERINGS
25.2 AWL INDIA
25.3 ALLOGA
25.4 BOLLORÉ LOGISTICS
25.5 CARDINAL HEALTH
25.6 C.H. ROBINSON
25.7 COLD CHAIN TECHNOLOGIES
25.8 CRYOPDP
25.9 DPD
25.10 DSV
25.11 FARMASOFT
25.12 JEENA & COMPANY
25.13 LUFTHANSA CARGO
25.14 A.P. MOLLER - MAERSK
25.15 MEDLINE
25.16 NIPPON EXPRESS
25.17 NOATUM LOGISTICS
25.18 OWENS & MINOR
25.19 OXIMIO
25.20 PHARMA LOGISTICS
25.21 PHOENIX GROUP
25.22 PAREXEL INTERNATIONAL
25.23 SEKO LOGISTICS
25.24 SINGAPORE POST
25.25 SINOTRANS
25.26 XPO LOGISTICS
25.27 YOURWAY
25.28 YUSEN LOGISTICS
26 REPORT SUMMARY
26.1 KEY TAKEAWAYS
26.2 STRATEGIC RECOMMENDATIONS
27 QUANTITATIVE SUMMARY
27.1 MARKET BY GEOGRAPHY
27.2 MARKET BY THERAPY AREA
27.3 MARKET BY ORIGIN
27.4 MARKET BY PRODUCT
27.5 MARKET BY FUNCTION
27.6 NORTH AMERICA BY THERAPY AREA
27.7 NORTH AMERICA BY ORIGIN
27.8 NORTH AMERICA BY PRODUCT
27.9 NORTH AMERICA BY FUNCTION
27.10 EUROPE BY THERAPY AREA
27.11 EUROPE BY ORIGIN
27.12 EUROPE BY PRODUCT
27.13 EUROPE BY FUNCTION
27.14 APAC BY THERAPY AREA
27.15 APAC BY ORIGIN
27.16 APAC BY PRODUCT
27.17 APAC BY FUNCTION
27.18 LATIN AMERICA BY THERAPY AREA
27.19 LATIN AMERICA BY ORIGIN
27.20 LATIN AMERICA BY PRODUCT
27.21 LATIN AMERICA BY FUNCTION
27.22 MIDDLE EAST & AFRICA AMERICA BY THERAPY AREA
27.23 MIDDLE EAST & AFRICA BY ORIGIN
27.24 MIDDLE EAST & AFRICA BY PRODUCT
27.25 MIDDLE EAST & AFRICA BY FUNCTION
28 APPENDIX
28.1 ABBREVIATIONS

ABOUT US:
Arizton Advisory and Intelligence is an innovative and quality-driven firm that offers cutting-edge research solutions to clients worldwide. We excel in providing comprehensive market intelligence reports and advisory and consulting services.

We offer comprehensive market research reports on consumer goods & retail technology, automotive and mobility, smart tech, healthcare, life sciences, industrial machinery, chemicals, materials, I.T. and media, logistics, and packaging. These reports contain detailed industry analysis, market size, share, growth drivers, and trend forecasts. 

Arizton comprises a team of exuberant and well-experienced analysts who have mastered generating incisive reports. Our specialist analysts possess exemplary skills in market research. We train our team in advanced research practices, techniques, and ethics to outperform in fabricating impregnable research reports. 

Call: +1-312-235-2040 
          +1 302 469 0707 
Mail: enquiry@arizton.com

This release was published on openPR.